Enhabit Inc. (EHAB)vsFresenius Medical Care Corporation (FMS)
EHAB
Enhabit Inc.
$13.67
+0.07%
HEALTHCARE · Cap: $690.85M
FMS
Fresenius Medical Care Corporation
$22.26
+1.04%
HEALTHCARE · Cap: $12.47B
Smart Verdict
WallStSmart Research — data-driven comparison
Fresenius Medical Care Corporation generates 1752% more annual revenue ($19.63B vs $1.06B). FMS leads profitability with a 5.0% profit margin vs -0.4%. FMS earns a higher WallStSmart Score of 62/100 (C+).
EHAB
Hold48
out of 100
Grade: D+
FMS
Buy62
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for EHAB.
Margin of Safety
+73.4%
Fair Value
$90.32
Current Price
$22.26
$68.06 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 86.7% YoY
Attractively priced relative to earnings
Reasonable price relative to book value
Growing faster than its price suggests
Areas to Watch
4.7% revenue growth
Distress zone — elevated risk
Smaller company, higher risk/reward
ROE of -0.5% — below average capital efficiency
4.2% earnings growth
Grey zone — moderate risk
ROE of 7.9% — below average capital efficiency
5.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : EHAB
The strongest argument for EHAB centers on Price/Book, EPS Growth.
Bull Case : FMS
The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.73 suggests the stock is reasonably priced for its growth.
Bear Case : EHAB
The primary concerns for EHAB are Revenue Growth, Altman Z-Score, Market Cap.
Bear Case : FMS
The primary concerns for FMS are EPS Growth, Altman Z-Score, Return on Equity. Thin 5.0% margins leave little buffer for downturns.
Key Dynamics to Monitor
EHAB profiles as a turnaround stock while FMS is a value play — different risk/reward profiles.
EHAB carries more volatility with a beta of 1.18 — expect wider price swings.
EHAB is growing revenue faster at 4.7% — sustainability is the question.
FMS generates stronger free cash flow (564M), providing more financial flexibility.
Bottom Line
FMS scores higher overall (62/100 vs 48/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Enhabit Inc.
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Enhabit, Inc. provides home health and hospice services in the United States.
Visit Website →Fresenius Medical Care Corporation
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?